Insider and Congress filings

Celestica Inc. (CLS)

Hardware, Equipment & Parts, listed on NYSE.

124 insider transactions5 Congress tradeslast filed Nov 5, 2026

Share
Download on the App StoreGet it on Google Play

Free on iOS and Android

Scan to get
the app

EarningsQ3 FY2026 · reported Oct 26, 2026

Q3 FY2026: Beat +12.6% on adjusted EPS. Revenue beat by 6.5%. Next report Jan 27, 2027.

EPS Q3 FY2026

Reported$3.30
Consensus$2.93

Revenue Q3 FY2026

Reported$5.75B
Consensus$5.39B

Beat 6

Consensus $3.48 a share on $6.42B of revenue, the analysts’ forecast.

Every quarter

Money managers13F filings for Jun 30, 2026

5

of the 97 fund managers GetSignal tracks list Celestica among their largest positions. D. E. Shaw & Co. held the most, $684.3M.

Tracked managers’ Q2 2026 moves

Viking Global Investorssold out−$466.2M
SRS Investmenttrimmed−$38.2M

Each manager’s 13F against the one before, priced at the Jun 30, 2026 close: an estimate, from each manager’s 15 largest moves. Not investment advice.

Every manager

Insider tradesForm 4 · 6 open-market filings shown

Six open-market sales, all under 10b5‑1 plans.

Aug 4, 2026Sep 23, 2026

Sales under a plan

6 of 6 under a plan

A median 1 business day from trade to filing. Form 4 is due within two.

Every filing

CongressSTOCK Act disclosures to the House and Senate

5 Congress disclosures shown, from 3 members.

17dMedian delayof the 45 day limit
3 buys · 2 sellsPurchases and sales in the disclosures shown

2 members of Congress report a position in CLS, by our estimate. Who holds it

Every Congress trade in CLSEvery disclosure
Companyfrom the company's filings and listing, as of Nov 10, 2026

About Celestica Inc.

Exchange
NYSE
Sector
Technology
Industry
Hardware, Equipment & Parts
Chief executive
Robert Andrew Mionis
Employees
23,803
Listed since
Jun 30, 1998
Market value
$28.1B
Price to earnings (12 mo)
20.8
Net income per share, as reported (12 mo)
$10.34
Dividend yield
-

www.celestica.com

GetSignal News1 article · newest first

GetSignal News

HeadlineSourceDate
Celestica says TSX has accepted its bid to repurchase up to 3,132,127 sharesCelestica said the bid is scheduled to run from November 3, 2026 until November 2, 2027, or until purchases are completed if sooner.Form 8-K and releaseOct 30, 2026

Written by GetSignal with AI from SEC filings and the company's own press releases; each article links to its source. Not investment advice.

Company news from every company we cover

Earnings6 reported quarters · next on Jan 27, 2027

Earnings

QuarterEPSEPS expectedRevenueRevenue expectedResult
Q3 FY2026reported Oct 26, 2026$3.30$2.93$5.7B$5.4BEPS beatRevenue beat
Q2 FY2026reported Jul 27, 2026$2.54$2.29$4.7B$4.3BEPS beatRevenue beat
Q1 FY2026reported Apr 27, 2026$2.16$2.08$4.0B$4.0BEPS beatRevenue in line
Q4 FY2025reported Jan 28, 2026$1.89$1.74$3.6B$3.5BEPS beatRevenue beat
Q3 FY2025reported Oct 27, 2025$1.58$1.47$3.2B$3.5BEPS beatRevenue miss
Q2 FY2025reported Jul 28, 2025$1.39$1.24$2.9B$2.8BEPS beatRevenue beat

Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag reads n/a only when a number is missing. Quarterly EPS is the figure set against the consensus, usually adjusted, so the quarters need not add up to the 12-month net income per share above. An estimate is a forecast made by analysts, not a company target.

Earnings call briefs1 call

Earnings call briefs

Written by GetSignal with AI from each earnings call; every brief quotes the executives' own words. Key facts are what the company said on the call, not our forecast. Not investment advice.

Earnings call briefs from every company we cover

Analysts

Analyst ratings and price targets

Past year Each firm's latest target, newest first

Each firm's latest price target on CLS, newest first
FirmRatingTargetActionDate
BarclaysOverweight$414Raised from $406
Goldman SachsConviction Buy$435Cut from $475
BMO CapitalOutperform$400Cut from $450
BernsteinOutperform$520Initiated
FBN SecuritiesOutperform$375Initiated
UBSBuy$430Target set
RBC CapitalNot stated$450Raised from $440
CIBCNot stated$500Raised from $480
Wolfe ResearchOutperform$475Target set
StifelNot stated$500Raised from $445
Rothschild & Co RedburnBuy$460Initiated
SusquehannaPositive$510Target set
TD SecuritiesNot stated$350Target set

Each firm's latest target from the past year, with the rating stated with its note. These are the firms' own views, not GetSignal's, and we do not endorse them. Not investment advice.

4 other firms rated CLS in the past year with no current target listed here. Ratings and targets come from licensed market data providers. A target is listed only after its firm and company are confirmed against a report of the note. As of Nov 11, 2026.

13F filings13F positions as of Jun 30, 2026

Institutional holders

875 institutions reported Celestica shares in 13F filings for Jun 30, 2026.
HolderValueSharesShares vs prior qtr% of shares out
FMR LLC$3.1B8,446,912+11.7%7.35%
JPMorgan Chase & Co.$1.3B3,874,584-12.9%3.37%
Vanguard Capital Management LLC$1.2B3,187,470+1.0%2.77%
Franklin Templeton Inc$1.0B2,777,601+5.1%2.42%
Jane Street Group, LLC$766.4M2,100,985-17.1%1.83%
CIBC World Market Inc.$757.8M2,079,718-1.1%1.81%
D. E. Shaw & Co., Inc.$684.3M1,876,165+88.6%1.63%
Connor, Clark & Lunn Investment Management Ltd.$674.2M1,846,032+10.6%1.61%
Value Aligned Research Advisors, LLC$575.1M1,576,402+5.7%1.37%
Arrowstreet Capital, Limited Partnership$554.9M1,521,260-30.5%1.32%
Bank of Montreal$545.4M1,497,067+6.5%1.30%
Norges Bank$544.8M1,494,469New1.30%

A 13F reports long US equity positions and is filed within 45 days of the quarter end, so these are positions as they stood on Jun 30, 2026. New: not in this holder's prior 13F as reported; a change of filer ID can also show as new. For a manager's whole book see the fund directory. What a 13F covers and leaves out is explained in our guide to Form 13F.

13F filings5 managers

Tracked fund managers holding CLS

ManagerValueSharesShare of book
D. E. Shaw & Co.Founded by David Shaw$684.3M1,876,1650.3%
Whale Rock Capital Management$538.6M1,476,4304.3%
SRS Investment Management$332.7M911,9273.1%
Ray DalioBridgewater Associates$120.6M330,6890.5%
Maverick CapitalLee Ainslie$4.7M12,782n/a

5 of the 97 fund managers we track list CLS shares among the largest positions in their latest 13F, filed for Q2 2026. A manager can hold it further down the book too, so this is a floor, not a count. Share of book is the position against the manager's whole disclosed 13F value.

Form 46 filings shown · newest filing first

Open-market insider trades

InsiderActionSharesPriceValueTrade dateDelay
(business days)
Robert MionisChief Executive OfficerSold · scheduled · 8 lines23,396$364.22$8.5MSep 23, 2026filed Sep 24, 20261d
Todd C. CooperPresidentSold · scheduled20,118$360.00$7.2MSep 23, 2026filed Sep 24, 20261d
Robert MionisChief Executive OfficerSold · scheduled · 6 lines23,496$362.39$8.5MAug 13, 2026filed Aug 14, 20261d
Robert MionisChief Executive OfficerSold · scheduled · 18 lines51,061$368.41$18.8MAug 5, 2026filed Aug 6, 20261d
Mandeep ChawlaChief Financial OfficerSold · scheduled · 15 lines16,117$369.32$6.0MAug 4, 2026filed Aug 6, 20262d
Robert MionisChief Executive OfficerSold · scheduled · 15 lines77,836$370.87$28.9MAug 4, 2026filed Aug 6, 20262d

One row is one filing, newest filing first. A filing that reported its trade in several tranches is summed, priced at the weighted average, and marked with its line count. Scheduled: set up in advance under a Rule 10b5-1 trading plan. The delay counts business days from the trade to the filing, the unit of Form 4's two business day deadline: weekends and federal holidays are skipped. How the filing itself works is explained in our guide to Form 4.

Other Form 4 activity (17)
InsiderEventSharesDate
Mandeep ChawlaPresidentStock award2,876Nov 5, 2026
Steven Gregg DorwartPresidentStock award1,017Aug 11, 2026
Todd AnkenmannChief Financial OfficerStock award2,453Nov 5, 2026
Jill KaleDirectorTax withholding7Sep 30, 2026
Jill KaleDirectorOption exercise96Sep 30, 2026
Robert CascellaDirectorTax withholding6Sep 30, 2026
Robert CascellaDirectorOption exercise52Sep 30, 2026
Todd AnkenmannChief Financial OfficerOther Form 4 entry (see filing)772Oct 1, 2026
Kulvinder AhujaDirectorStock award133Aug 11, 2026
Robert CascellaDirectorStock award142Aug 11, 2026
Francoise ColpronDirectorStock award203Aug 11, 2026
Jill KaleDirectorStock award190Aug 11, 2026
Laurette T. KoellnerDirectorStock award317Aug 11, 2026
Amar MaletiraDirectorStock award142Aug 11, 2026
Christopher W. ColpittsDirectorStock award190Aug 11, 2026
David ReederDirectorStock award133Aug 11, 2026
Robert MionisChief Executive OfficerStock award1,271Aug 11, 2026

Awards, option exercises, shares withheld to cover tax and gifts all file on the same form as a purchase or a sale. None of them is a decision to trade, so they sit here rather than beside the ones that are.

STOCK Act5 disclosures of 5 on record · median 17d of the 45 allowed

Congress trades in CLS

Since the trade: the stock's move from its estimated entry price (a purchase) or estimated exit price (a sale) to its current price, the latest close we hold. Not the member's result.

MemberTypeActionAmount disclosedSince the tradeTrade dateDisclosedDelay
Cleo FieldsStockPurchase$15,001 - $50,000-35.8% since the tradeEstimated entry price $349.01, close on Mon Nov 3, 2025Current price $223.89, close on Tue Nov 10Nov 3, 2025Nov 19, 202516d
Cleo FieldsStockPurchase$15,001 - $50,000-35.0% since the tradeEstimated entry price $344.48, close on Fri Oct 31, 2025Current price $223.89, close on Tue Nov 10Oct 31, 2025Nov 12, 202512d
Val T. HoyleSpouseStockSale$1,001 - $15,000-13.1% since the saleEstimated exit price $257.64, close on Tue Sep 23, 2025Current price $223.89, close on Tue Nov 10Sep 23, 2025Oct 10, 202517d
Roger MarshallDependent childStockPurchase$1,001 - $15,000+3140.1% since the tradeEstimated entry price $6.91, close on Mon Oct 28, 2019Current price $223.89, close on Tue Nov 10Oct 28, 2019Dec 11, 201944d
Roger MarshallDependent childStockSale$1,001 - $15,000+2803.9% since the saleEstimated exit price $7.71, close on Wed Nov 6, 2019Current price $223.89, close on Tue Nov 10Nov 6, 2019Dec 11, 201935d

Estimated prices are the stock's closing price on the trade date. A disclosure gives a value band, not the price paid. Not investment advice. After a sale a positive figure means the stock kept rising after it.

Every Congress trade in CLS filterable by party, chamber, type and account.

STOCK Act2 members · estimate, as of Nov 10, 2026

Members of Congress reporting a position

2 members report a position (estimated).
MemberParty, chamberEstimated positionShare of their portfolio
Cleo FieldsDemocrat · House$15,001 - $50,0000.1%
Lucy McBathDemocrat · House$1,001 - $15,0000.1%

The largest estimated position is in the $15,001 - $50,000 band. Estimate, as of Nov 10, 2026. Each position is modelled from the member's disclosed transactions and annual filings: the midpoint of each disclosed band, marked to the latest close we hold. It is a rough estimate of a reported position, not a figure from a filing, which is why it is shown as a band. Share of portfolio sets that estimate against the member's whole estimated public-stock portfolio.

Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.

On Form 4, code P is an open-market purchase and S an open-market sale; a sale marked scheduled was set up in advance under a Rule 10b5-1 plan. Awards, option exercises, tax withholding and gifts (A, M, F and G) are listed under Other Form 4 activity and never counted as either.

A STOCK Act disclosure gives each trade as a band of dollar values, which we do not narrow, and is due within 45 days of the trade. An option is described by its underlying company's name; its row says it is an option.

Data as of Nov 11, 2026.

Methodology · Guide to Form 4 · Guide to the STOCK Act

Questions

What the filings on CLS show and how current they are.

Are insiders buying or selling CLS?

Across the 6 most recent open-market filings shown here, 0 were purchases and 6 were sales. 6 were scheduled in advance under a Rule 10b5-1 plan.

Which members of Congress have traded CLS?

Cleo Fields, Val T. Hoyle and Roger Marshall disclosed CLS transactions in the filings shown here.

Which members of Congress hold CLS?

2 members of Congress report a position in CLS in the estimate we hold as of Nov 10, 2026. The estimated positions belong to Cleo Fields and Lucy McBath. The estimate is built from disclosed transactions and annual filings, so it is shown as a band rather than a figure from a filing.

How quickly are CLS trades disclosed?

Insider filings on this page reached the public a median of 1 business day after the transaction (weekends and federal holidays skipped), against the two business days Form 4 allows. Congressional disclosures took a median of 17 days, against the 45 the STOCK Act allows.

Related companies

traded by the same members

See every company we track